Interventions to Improve COVID-19 Vaccine Hesitancy

Area of Science:

• Rheumatology
• Immunology
• Public Health

Background:

• Low Coronavirus disease 2019 (COVID-19) vaccine uptake is observed in patients with rheumatic conditions, despite their increased risk of adverse outcomes.
• This disparity is more significant in historically marginalized populations disproportionately affected by the COVID-19 pandemic.
• Key barriers include healthcare mistrust, vaccine misinformation, fear of rheumatic disease flares, and inconsistent medical advice.

Purpose of the Study:

• To investigate reasons for low COVID-19 vaccine uptake in individuals with rheumatic conditions.
• To evaluate the effectiveness of multimodal strategies and community partnerships in improving vaccine confidence and uptake, particularly in underserved communities.

Main Methods:

• Two randomized controlled trials are currently investigating the impact of multimodal strategies.
• Community partnerships are being leveraged to disseminate accurate COVID-19 vaccine information.
• Interventions aim to reduce vaccine hesitancy and encourage uptake.

Main Results:

• Ongoing studies are evaluating the effectiveness of community-based interventions.
• Preliminary data suggests potential for multimodal strategies to increase vaccine confidence.
• Further results are pending from the randomized controlled trials.

Conclusions:

• Addressing low COVID-19 vaccine uptake in rheumatic disease patients, especially marginalized groups, is critical.
• Multimodal strategies and community engagement show promise in overcoming hesitancy.
• Future research will confirm the efficacy of these interventions in improving public health outcomes.